CLGNCollPlant Biotechnologies Ltd

Nasdaq collplant.com


$ 5.00 $ -0.13 (-2.5 %)    

Friday, 23-Aug-2024 15:56:57 EDT
QQQ $ 478.50 $ -1.43 (-0.3 %)
DIA $ 413.83 $ 0.98 (0.24 %)
SPY $ 562.93 $ -0.26 (-0.05 %)
TLT $ 98.11 $ -0.54 (-0.55 %)
GLD $ 232.50 $ -0.98 (-0.42 %)
$ 5.06
$ 4.09 x 100
-- x --
-- - --
$ 4.10 - $ 7.88
1,423
na
57.95M
$ 0.76
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 hc-wainwright--co-reiterates-buy-on-collplant-biotechnologies-maintains-11-price-target

HC Wainwright & Co. analyst Swayampakula Ramakanth reiterates CollPlant Biotechnologies (NASDAQ:CLGN) with a Buy and mai...

 ef-hutton-maintains-buy-on-collplant-biotechnologies-maintains-14-price-target

EF Hutton analyst Jason Kolbert maintains CollPlant Biotechnologies (NASDAQ:CLGN) with a Buy and maintains $14 price target.

Core News & Articles

3D Printed Breast implants consisting of 200cc in volume of CollPlant's rhCollagen-based bioinks produced on a Stratasys...

 ef-hutton-initiates-coverage-on-collplant-biotechnologies-with-buy-rating-announces-price-target-of-14

EF Hutton analyst Jason Kolbert initiates coverage on CollPlant Biotechnologies (NASDAQ:CLGN) with a Buy rating and announce...

 collplant-reports-successful-bio-printing-of-200cc-breast-implants-and-additional-pre-clinical-data

Bio-printing technology now enables fabrication of 200cc implant size and above to address future commercial demand Interim ...

 hc-wainwright--co-reiterates-buy-on-collplant-biotechnologies-maintains-11-price-target

HC Wainwright & Co. analyst Swayampakula Ramakanth reiterates CollPlant Biotechnologies (NASDAQ:CLGN) with a Buy and mai...

 collplant-biotechnologies-q1-adj-035-inline-sales-9800k-miss-60000k-estimate

CollPlant Biotechnologies (NASDAQ:CLGN) reported quarterly losses of $(0.35) per share which met the analyst consensus estimate...

 hc-wainwright--co-reiterates-buy-on-collplant-biotechnologies-maintains-11-price-target

HC Wainwright & Co. analyst Swayampakula Ramakanth reiterates CollPlant Biotechnologies (NASDAQ:CLGN) with a Buy and mai...

 collplant-biotechnologies-q4-adj-eps-035-misses-007-estimate-sales-29900k-miss-856m-estimate

CollPlant Biotechnologies (NASDAQ:CLGN) reported quarterly Adj losses of $(0.35) per share which missed the analyst consensus e...

 earnings-scheduled-for-april-4-2024

Companies Reporting Before The Bell • Conagra Brands (NYSE:CAG) is likely to report quarterly earnings at $0.65 per share on r...

 collplant-biotechnologies-issues-letter-to-shareholders

Dear Shareholders,As we look toward a promising and exciting year ahead, I am proud to reflect on CollPlant's main achievem...

 collplant-biotechnologies-begins-preclinical-trial-with-commercial-size-regenerative-breast-implants

CollPlant Biotechnologies (NASDAQ:CLGN), a regenerative and aesthetics medicine company developing innovative technologies and ...

 hc-wainwright--co-reiterates-buy-on-collplant-biotechnologies-maintains-11-price-target

HC Wainwright & Co. analyst Swayampakula Ramakanth reiterates CollPlant Biotechnologies (NASDAQ:CLGN) with a Buy and mai...

 earnings-scheduled-for-november-29-2023

Companies Reporting Before The Bell • CollPlant Biotechnologies (NASDAQ:CLGN) is likely to report quarterly loss at $0.13 per ...

 collplant-biotechnologies-q3-adj-eps-035-misses-013-estimate-sales-4300k-miss-350m-estimate

CollPlant Biotechnologies (NASDAQ:CLGN) reported quarterly adjusted losses of $(0.35) per share which missed the analyst consen...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION